Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beckles, M. A.
Right arrow Articles by Rudd, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beckles, M. A.
Right arrow Articles by Rudd, R. M.
(Chest. 2003;123:97S-104S.)
© 2003 American College of Chest Physicians

Initial Evaluation of the Patient With Lung Cancer*

Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes

Michael A. Beckles, MB, BS; Stephen G. Spiro, MD; Gene L. Colice, MD, FCCP and Robin M. Rudd, MD

* From the Department of Respiratory Medicine (Dr. Beckles), Royal Free Hospital, London, UK; Department of Respiratory Medicine (Dr. Spiro), Middlesex Hospital, London, UK; Pulmonary, Critical Care and Respiratory Services (Dr. Colice), Washington Hospital Center, Washington, DC; and Department of Medical Oncology (Dr. Rudd), St. Bartholomew’s Hospital, Smithfield, London, UK.

Correspondence to: Stephen G. Spiro, MD, Department of Respiratory Medicine, The Middlesex Hospital, Mortimer St, London W1T 3AA, United Kingdom; e-mail: stephen.spiro{at}uclh.org

This chapter describes the components of the initial evaluation for a patient either suspected or known to have lung cancer. The components of the initial evaluation are based on the recognized manifestations of localized lung cancer, ie, symptoms referable to the primary tumor, intrathoracic spread of lung cancer, and patterns of metastatic dissemination. Features of the history and physical signs may be useful indicators of the extent of disease. A standardized evaluation, relying on symptoms, signs, and routinely available laboratory tests, can serve as a useful screen for metastatic disease. Also described are the common features of the various paraneoplastic syndromes associated with lung cancer.

Key Words: evaluation • laboratory test • paraneoplastic • signs • symptoms






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.